Obi Umeh, MD, MSc, VP, Franchise Global Program Leader at Takeda, discusses interim results from a study investigating mezagitamab for the treatment of patients with IgA nephropathy. This…
Dana Rizk, MD, professor of medicine at the University of Alabama at Birmingham, discusses the approval of Fabhalta (iptacopan) for adults with IgA nephropathy. Iptacopan, a Factor B…
Anand Reddy, MRCP (UK), FACP, FASN, Permian Regional Medical Center, Andrews, Texas; and Richard Lafayette, MD, FASN, professor of medicine and director of the Stanford Glomerular Disease Center,…
From different backgrounds and lifestyles, Elle, Jennifer, Tony, and Sean discuss their first-hand experiences with IgA nephropathy and the associated challenges of living with this rare disease.
Sean Converse was diagnosed with IgA nephropathy in late 2022 following an acute upper respiratory illness. Sean discusses challenges and his experience with IgA nephropathy.
Lauren Levy, MS, RDN, CSR, owner of Happy Health Nutrition, LLC, discusses considerations for kidney-friendly diets for patients with IgA nephropathy. She also discusses what parts of the…
Jonathan Barratt, MD, University of Leicester, UK, discusses the need for improved continuity of care for patients with IgA nephropathy. Professor Barratt notes that the rarity of the…
Julian, a kidney recipient, reflects on his experience with IgA nephropathy. Thanks to a successful transplant, Julian is able to continue his career. “I’m living a healthy, normal…
Jennifer Vaughan, APRN, and Kenneth K. Afenya, MD, of Lex Kidney Care, Lexington, Kentucky, discuss the basics of IgA nephropathy, including signs and symptoms, as well as epidemiology…
